Cargando…
An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery
The development of vaccines is one of the most significant medical accomplishments which has helped to eradicate a large number of diseases. It has undergone an evolutionary process from live attenuated pathogen vaccine to killed whole organisms or inactivated toxins (toxoids), each of them having i...
Autores principales: | Petkar, Kailash C., Patil, Suyash M., Chavhan, Sandip S., Kaneko, Kan, Sawant, Krutika K., Kunda, Nitesh K., Saleem, Imran Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066039/ https://www.ncbi.nlm.nih.gov/pubmed/33801614 http://dx.doi.org/10.3390/pharmaceutics13040455 |
Ejemplares similares
-
Enhanced Antihypertensive Activity of Candesartan Cilexetil Nanosuspension: Formulation, Characterization and Pharmacodynamic Study
por: Detroja, Chetan, et al.
Publicado: (2011) -
Microbes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment
por: Sawant, Shruti S., et al.
Publicado: (2020) -
In Vitro Characterization of Inhalable Cationic Hybrid Nanoparticles as Potential Vaccine Carriers
por: Alfagih, Iman M., et al.
Publicado: (2021) -
Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro
por: Vartak, Richa, et al.
Publicado: (2021) -
Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants
por: Anggraeni, Rahmi, et al.
Publicado: (2022)